BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 12393398)

  • 1. A novel diagnostic screen for defects in the Fanconi anemia pathway.
    Shimamura A; Montes de Oca R; Svenson JL; Haining N; Moreau LA; Nathan DG; D'Andrea AD
    Blood; 2002 Dec; 100(13):4649-54. PubMed ID: 12393398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function of the Fanconi anemia pathway in Fanconi anemia complementation group F and D1 cells.
    Siddique MA; Nakanishi K; Taniguchi T; Grompe M; D'Andrea AD
    Exp Hematol; 2001 Dec; 29(12):1448-55. PubMed ID: 11750104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Chinese hamster FANCG/XRCC9 mutant NM3 fails to express the monoubiquitinated form of the FANCD2 protein, is hypersensitive to a range of DNA damaging agents and exhibits a normal level of spontaneous sister chromatid exchange.
    Wilson JB; Johnson MA; Stuckert AP; Trueman KL; May S; Bryant PE; Meyn RE; D'Andrea AD; Jones NJ
    Carcinogenesis; 2001 Dec; 22(12):1939-46. PubMed ID: 11751423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current knowledge on the pathophysiology of Fanconi anemia: from genes to phenotypes.
    Yamashita T; Nakahata T
    Int J Hematol; 2001 Jul; 74(1):33-41. PubMed ID: 11530803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FANCD2 Western blot as a diagnostic tool for Brazilian patients with Fanconi anemia.
    Pilonetto DV; Pereira NF; Bitencourt MA; Magdalena NI; Vieira ER; Veiga LB; Cavalli IJ; Ribeiro RC; Pasquini R
    Braz J Med Biol Res; 2009 Mar; 42(3):237-43. PubMed ID: 19287902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positional cloning of a novel Fanconi anemia gene, FANCD2.
    Timmers C; Taniguchi T; Hejna J; Reifsteck C; Lucas L; Bruun D; Thayer M; Cox B; Olson S; D'Andrea AD; Moses R; Grompe M
    Mol Cell; 2001 Feb; 7(2):241-8. PubMed ID: 11239453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subtyping analysis of Fanconi anemia by immunoblotting and retroviral gene transfer.
    Pulsipher M; Kupfer GM; Naf D; Suliman A; Lee JS; Jakobs P; Grompe M; Joenje H; Sieff C; Guinan E; Mulligan R; D'Andrea AD
    Mol Med; 1998 Jul; 4(7):468-79. PubMed ID: 9713825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the Fanconi anemia pathway by monoubiquitination.
    Gregory RC; Taniguchi T; D'Andrea AD
    Semin Cancer Biol; 2003 Feb; 13(1):77-82. PubMed ID: 12507559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Fanconi anemia protein, FANCE, promotes the nuclear accumulation of FANCC.
    Taniguchi T; D'Andrea AD
    Blood; 2002 Oct; 100(7):2457-62. PubMed ID: 12239156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical, genetic and cytogenetic study of Fanconi anemia in an Indian population.
    Korgaonkar S; Ghosh K; Vundinti BR
    Hematology; 2010 Feb; 15(1):58-62. PubMed ID: 20132664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi anemia screening by diepoxybutane and mitomicin C tests in Korean children with bone marrow failure syndromes.
    Kook H; Cho D; Cho SH; Hong WP; Kim CJ; Park JY; Yoon WS; Ryang DW; Hwang TJ
    J Korean Med Sci; 1998 Dec; 13(6):623-8. PubMed ID: 9886171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fanconi anemia ID2 complex: dueling saxes at the crossroads.
    Boisvert RA; Howlett NG
    Cell Cycle; 2014; 13(19):2999-3015. PubMed ID: 25486561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FANCC, FANCE, and FANCD2 form a ternary complex essential to the integrity of the Fanconi anemia DNA damage response pathway.
    Gordon SM; Alon N; Buchwald M
    J Biol Chem; 2005 Oct; 280(43):36118-25. PubMed ID: 16127171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive diepoxybutane test in only one of two brothers found to be compound heterozygotes for Fanconi's anaemia complementation group C mutations.
    Dokal I; Chase A; Morgan NV; Coulthard S; Hall G; Mathew CG; Roberts I
    Br J Haematol; 1996 Jun; 93(4):813-6. PubMed ID: 8703809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.
    Adachi D; Oda T; Yagasaki H; Nakasato K; Taniguchi T; D'Andrea AD; Asano S; Yamashita T
    Hum Mol Genet; 2002 Dec; 11(25):3125-34. PubMed ID: 12444097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordination of the recruitment of the FANCD2 and PALB2 Fanconi anemia proteins by an ubiquitin signaling network.
    Bick G; Zhang F; Meetei AR; Andreassen PR
    Chromosoma; 2017 Jun; 126(3):417-430. PubMed ID: 27277787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic instability in mice is greater in Fanconi anemia caused by deficiency of Fancd2 than Fancg.
    Reliene R; Yamamoto ML; Rao PN; Schiestl RH
    Cancer Res; 2010 Dec; 70(23):9703-10. PubMed ID: 21118969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functionally active retrovirus vector for gene therapy in Fanconi anemia group C.
    Walsh CE; Grompe M; Vanin E; Buchwald M; Young NS; Nienhuis AW; Liu JM
    Blood; 1994 Jul; 84(2):453-9. PubMed ID: 7517716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic correction of primary Fanconi anemia T cells with retroviral vectors as a diagnostic tool.
    Hanenberg H; Batish SD; Pollok KE; Vieten L; Verlander PC; Leurs C; Cooper RJ; Göttsche K; Haneline L; Clapp DW; Lobitz S; Williams DA; Auerbach AD
    Exp Hematol; 2002 May; 30(5):410-20. PubMed ID: 12031647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of chromosome breakage in non-mosaic and mosaic patients with Fanconi anemia, relatives, and patients with other inherited bone marrow failure syndromes.
    Fargo JH; Rochowski A; Giri N; Savage SA; Olson SB; Alter BP
    Cytogenet Genome Res; 2014; 144(1):15-27. PubMed ID: 25227706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.